PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
18-Aug-2025 Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis Precigen
18-Aug-2025 BellaSeno Establishes High-Profile Clinical Advisory Board BellaSeno
15-Aug-2025 GenesisCare Further Expands Its Adaptive Radiotherapy MR Linac Network GenesisCare
15-Aug-2025 On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours KFSHRC
15-Aug-2025 Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy Tiziana Life Sciences
15-Aug-2025 Santhera extends Highbridge convertible bond to 30th September 2025 Santhera
15-Aug-2025 GenesisCare Further Expands Its Adaptive Radiotherapy MR Linac Network GenesisCare
15-Aug-2025 Corza Medical Launches Biomedical Textiles Innovation Lab to Accelerate OEM Product Development Corza Medical
15-Aug-2025 First Disease-Modifying Type 1 Diabetes Treatment licensed to delay the onset of symptomatic Stage 3 autoimmune type 1 diabetes (T1D) in adult and paediatric patients 8 years of age and older with Stage 2 T1D Sanofi
12-Aug-2025 PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases PureTech
12-Aug-2025 Panthera Biopartners secures investment from LDC to accelerate expansion Panthera Biopartners
12-Aug-2025 FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response FoRx Therapeutics
12-Aug-2025 FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy Tiziana Life Sciences
12-Aug-2025 LIEBHERR LAUNCHES NEW UNDER-BENCH FRIDGE AND FREEZERS FOR LABORATORY AND HEALTHCARE PROVIDERS LIEBHERR
12-Aug-2025 Cambridge Cognition launches Speaker Identification Solution to Safeguard Clinical Trial Integrity Cambridge Cognition
12-Aug-2025 Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept Mabylon AG
08-Aug-2025 Global Long Term Care Market to Surpass USD 2.03 Trillion by 2033, Driven by Aging Population and Rising Chronic Illnesses Ameco Research
08-Aug-2025 Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Genmab
08-Aug-2025 Genmab Announces Financial Results for the First Half of 2025 Genmab
08-Aug-2025 Galapagos Creates New Subscription Right Plan Galapagos